Table 1 Magnesium sulphate vs placebo/no treatment: primary outcomes[33]
Primary outcomes | RR, 95% CI | Number of trials; participants |
|---|---|---|
Death or cerebral palsy | 0.85, 0.74 to 0.98* | four trials; 4446 infants |
Death (fetal and later) | 0.95, 0.80 to 1.12 | four trials; 4446 infants |
Cerebral palsy | 0.71, 0.55 to 0.91* | four trials; 4446 infants |
Any neurological impairment | 1.03, 0.87 to 1.21 | one trial; 1255 infants |
Death or substantial gross motor dysfunction | 0.84, 0.71 to 1.00 | three trials; 4387 infants |